Citation Impact

Citing Papers

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
2008 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Atorvastatin and fluvastatin are associated with dose‐dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
2016
Psychological Stress and Disease
2007 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Cancer Statistics, 2021
2021 Standout
Induction of Human Immunodeficiency Virus 1 Replication by Human Herpesvirus 8
2001
Frailty, HIV Infection, and Mortality in an Aging Cohort of Injection Drug Users
2013
Selenium in the maintenance and therapy of HIV-infected patients
1994
HIV viral load markers in clinical practice
1996
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
2012
Interactions between Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Type 1 Infection in African Women: Opportunities for Intervention
2000
Human Immunodeficiency Virus Acquisition Associated with Genital Ulcer Disease and Herpes Simplex Virus Type 2 Infection: A Nested Case‐Control Study in Rakai, Uganda
2003
Syndemics and the biosocial conception of health
2017 Standout
Hepatocellular carcinoma
2018 Standout
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
2000 Standout
Coinfection with Herpes Simplex Virus Type 2 Is Associated with Reduced HIV‐Specific T Cell Responses and Systemic Immune Activation
2008
Serum Cholesterol and Statin Use Predict Virological Response to Peginterferon and Ribavirin Therapy†,‡
2010
Multi-input chemical control of protein dimerization for programming graded cellular responses
2019 StandoutNobel
Antioxidants Inhibit Stimulation of HIV Transcription
1993
Hepatitis C Virus in the HIV-Infected Patient
2006
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
1996
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial
2007 Standout
Antioxidant Defenses Influence HIV-1 Replication and Associated Cytopathic Effects
1998
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
1997 Standout
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Differences in Human Immunodeficiency Virus Care and Treatment Among Subpopulations in the United States
2013
The REDCap consortium: Building an international community of software platform partners
2019 Standout
Antiretroviral Therapy for HIV Infection
1998
Selenium Supplementation Suppresses Tumor Necrosis Factor α-Induced Human Immunodeficiency Virus Type 1 Replication in Vitro
1997
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration
1999
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Stress as a predictor of symptomatic genital herpes virus recurrence in women with human immunodeficiency virus
2003
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 Standout
Tissue-specific functions of individual glutathione peroxidases
1999 Standout
HIV Transmission Risk Behaviors among HIV‐Infected Persons Who Are Successfully Linked to Care
2008
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1997 Standout
Opportunities for interventionDiscussing physical abuse during prenatal care visits1
2000
Missed Visits and Mortality among Patients Establishing Initial Outpatient HIV Treatment
2008
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
1999 StandoutNobel
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
2013
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Association of tenofovir exposure with kidney disease risk in HIV infection
2012
The importance of selenium to human health
2000 Standout
Effect of Plasmodium falciparum malaria on concentration of HIV-1-RNA in the blood of adults in rural Malawi: a prospective cohort study
2005
miRNA–target chimeras reveal miRNA 3′-end pairing as a major determinant of Argonaute target specificity
2015 StandoutNobel
Malaria
2013 Standout
Genital Herpes and Public Health
2000
The role of sexually transmitted diseases in HIV transmission
2004 Standout
Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection
2003
Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure
1998
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
1998 Standout
An internationally generalizable risk index for mortality after one year of antiretroviral therapy
2012
Association of Plasma Human Immunodeficiency Virus Type 1 RNA Level withRisk of Clinical Progression in Patients with Advanced Infection
1996
Durability and Outcome of Initial Antiretroviral Treatments Received during 2000–2005 by Patients in the Swiss HIV Cohort Study
2008
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS
1996
Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C
2018
Stimulation of Glutathione Peroxidase Activity Decreases HIV Type 1 Activation after Oxidative Stress
1994
State of Telehealth
2016 Standout
Pharmacokinetic Evaluation of Rifabutin in Combination with Lopinavir‐Ritonavir in Patients with HIV Infection and Active Tuberculosis
2009
Global control of hepatitis C: where challenge meets opportunity
2013
Changes in Plasma Human Immunodeficiency Virus Type 1 RNA Associated with Herpes Simplex Virus Reactivation and Suppression
2002
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection
2012
Does an Index Composed of Clinical Data Reflect Effects of Inflammation, Coagulation, and Monocyte Activation on Mortality Among Those Aging With HIV?
2012
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
The Effect of Acute Infectious Illnesses on Plasma Human Immunodeficiency Virus (HIV) Type 1 Load and the Expression of Serologic Markers of Immune Activation among HIV‐Infected Adults
1998
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
Distribution of Health Care Expenditures for HIV-Infected Patients
2006
Patterns of engagement in care by HIV-infected adults: South Carolina, 2004–2006
2009
Contribution of HIV‐1 Infection to Acquisition of Sexually Transmitted Disease: A 10‐Year Prospective Study
2005
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers
2011
Racial Differences in End-Stage Renal Disease Rates in HIV Infection versus Diabetes
2007
Hepatocellular Carcinoma
2011 Standout
Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma
2011
Natural history of hepatitis C
2014
Association between cervical shedding of herpes simplex virus and HIV-1
2002
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Hepatocellular carcinoma
2022 Standout
Treatment of HCV Infection by Targeting MicroRNA
2013 Standout
Efavirenz
2001
The effect of maternal viral load on the risk of perinatal transmission of HIV-1
1997
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Fluorine in medicinal chemistry
2007 Standout
Hepatocellular Carcinoma
2019 Standout
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
2013
Human Immunodeficiency Virus Induces a Dual Regulation of Bcl-2, Resulting in Persistent Infection of CD4+T- or Monocytic Cell Lines
1998 StandoutNobel
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
Utilization of Surveillance for Hepatocellular Carcinoma Among Hepatitis C Virus–Infected Veterans in the United States
2011
Displacement of Linker for Activation of T Cells from the Plasma Membrane Due to Redox Balance Alterations Results in Hyporesponsiveness of Synovial Fluid T Lymphocytes in Rheumatoid Arthritis
2000
Recognition and Reaction of Metallointercalators with DNA
1999 Standout
Redox regulation of signal transduction: tyrosine phosphorylation and calcium influx.
1994
Protease inhibitor therapy for hepatitis C virus-infection
2018
Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection
2014
From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection
1999 Standout
Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4+CD8−CD3+ thymocytes through sustained induction of Bcl-2
2001 StandoutNobel
A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1
2000
Glutathione deficiency is associated with impaired survival in HIV disease
1997
Requirement for Generation of H 2 O 2 for Platelet-Derived Growth Factor Signal Transduction
1995 StandoutScience
Screening for Hepatitis C Virus Infection in Adolescents and Adults
2020
A Systematic Review of the Epidemiologic Interactions Between Classic Sexually Transmitted Diseases and HIV
2001
Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathione peroxidase deficiency.
1994
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
2015 Standout
Consequences of Nucleic Acid Amplification Testing for Blood Transfusion Centres
1998
Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
2009
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Fluorescent Chemosensors Based on Spiroring-Opening of Xanthenes and Related Derivatives
2011 Standout
Influence of Alternative Thresholds for Initiating HIV Treatment on Quality-Adjusted Life Expectancy: A Decision Model
2008
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors
2004 StandoutNobel
Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement
2013
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Probing Biomolecule Recognition with Electron Transfer:  Electrochemical Sensors for DNA Hybridization
1997
Antioxidants and immune response in aged persons: overview of present evidence
1995

Works of L Molé being referenced

The immunology case registry
2001
Development and Verification of a “Virtual” Cohort Using the National VA Health Information System
2006
The Impact of Active Herpes Simplex Virus Infection on Human Immunodeficiency Virus Load
1997
A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
2011
Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies
2007
Intracellular Glutathione Levels in T Cell Subsets Decrease in HIV-Infected Individuals
1992
Retention in Care: A Challenge to Survival with HIV Infection
2007
Clinical Case Registries: Simultaneous Local and National Disease Registries for Population Quality Management
2009
Predictors of response of U.S. veterans to treatment for the hepatitis C virus
2007
Decreased Medical Expenditures for Care of HIV-Seropositive Patients
1999
Diurnal and short-term stability of HIV virus load as measured by gene amplification.
1994
Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals
2017
Human Immunodeficiency Virus Reverse Transcriptase Codon 215 Mutations Diminish Virologic Response to Didanosine-Zidovudine Therapy in Subjects with Non-Syncytium-Inducing Phenotype
1996
Stabilities of quantitative plasma culture for human immunodeficiency virus, RNA, and p24 antigen from samples collected in VACUTAINER CPT and standard VACUTAINER tubes
1994
Determination of human immunodeficiency virus RNA in plasma and cellular viral DNA genotypic zidovudine resistance and viral load during zidovudine-didanosine combination therapy
1995
Nonisotopic hybridization assay for determination of relative amounts of genotypic human immunodeficiency virus type 1 zidovudine resistance
1995
Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes
1995
Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy.
2005
CD20 expression is increased on B lymphocytes from HIV-infected individuals.
1992
Tolerance and Pharmacokinetic Interactions of Rifabutin and Clarithromycin in Human Immunodeficiency Virus-Infected Volunteers
1998
Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort
2013
Rankless by CCL
2026